Genetic architecture of the F7 gene in a Spanish population: Implication for mapping complex diseases and for functional assays

Clinical Genetics

Volumn 69, Issue 5, 2006, Pages 420-428

  Sabater Lleal, M ^a   Almasy, L ^b   Martinez Marchan E ^a   Martinez Sanchez E ^a   Souto, R ^a   Blangero, J ^b   Souto, Jc ^a   Fontcuberta, J ^a   Soria, José M ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cardiovascular risk; Complex disease; F7 variation; FVII levels; Linkage analysis; Polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 7; DNA;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; EXON; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; QUANTITATIVE TRAIT LOCUS; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; THROMBOPHILIA;

ALLELES; AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASES; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; DNA MUTATIONAL ANALYSIS; FACTOR VII; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ALIGNMENT; SPAIN; THROMBOPHILIA;

EID: 33646133006     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00608.x     Document Type: Article

References (41)

1. de Maat MP, Green F, de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997: 17 (1): 1918-1923.
2. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993: 342 (8879): 1076-1079.
3. Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997: 17 (8): 1539-1544.
4. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990: 76 (4): 731-736.
5. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977: 74 (12): 5260-5264.
6. O'Hara PJ, Grant FJ, Haldeman BA et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987: 84 (15): 5158-5162.
7. Pfeiffer RA, Ott R, Gilgenkrantz S, Alexandre P. Deficiency of coagulation factors VII and X associated with deletion of a chromosome 13 (q34). Evidence from two cases with 46,XY,t (13;Y) (q11;q34). Hum Genet 1982: 62 (4): 358-360.
8. Gilgenkrantz S, Briquel ME, Andre E et al. Structural genes of coagulation factors VII and X located on 13q34. Ann Genet 1986: 29 (1): 32-35.
9. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991: 11 (3): 540-546.
10. Bernardi F, Patracchini P, Gemmati D et al. Molecular analysis of factor VII deficiency in Italy: A frequent mutation (FVII Lazio) in a repeated intronic region. Hum Genet 1993: 92 (5): 446-450.
11. Bernardi F, Castaman G, Redaelli R et al. Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala→Val) and X (334Ser→Pro). Hum Mol Genet 1994: 3 (7): 1175-1177.
12. Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5′ - flanking region. J Biol Chem 1996: 271 (3): 1738-1747.
13. Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F. PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res 1991: 19 (16): 4570.
14. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993: 90 (5): 575-576.
15. Marchetti G, Ferrati M, Patracchini P, Redaelli R, Bernardi F. A missense mutation (178Cys→Tyr) and two neutral dimorphisms (115His and 333Ser) in the human coagulation factor VII gene. Hum Mol Genet 1993: 2 (7): 1055-1056.
16. Tamary H, Fromovich Y, Shalmon L et al. Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews. Thromb Haemost 1996: 76 (3): 283-291.
17. van't Hooft FM, Silveira A, Tornvall P et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 1999: 93 (10): 3432-3441.
18. Peyvandi F, Mannucci PM, Bucciarelli P et al. A novel polymorphism in intron 1a of the human factor VII gene (G73A): Study of a healthy Italian population and of 190 young survivors of myocardial infarction. Br J Haematol 2000: 108 (2): 247-253.
19. Millar DS, Kemball-Cook G, McVey JH et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000: 107 (4): 327-342.
20. Souto JC, Almasy L, Borrell M et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Genetic analysis of idiopathic Thrombophilia. Am J Hum Genet 2000: 67 (6): 1452-1459.
21. Soria JM, Almasy L, Souto JC, Sabater-Lleal M, Fontcuberta J, Blangero J. Dissection of a human quantitative trait locus: F7 gene and factor VII levels. Human Biol 2005: 77 (5): 561-575.
22. Souto JC, Almasy L, Borrell M et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000: 101 (13): 1546-1551.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16 (3): 1215.
24. Sabater-Lleal M, Martinez-Marchan E, Martinez-Sanchez E et al. Complexity of the genetic contribution to factor VII deficiency in two Spanish families: Clinical and biological implications. Haematologica 2003: 88 (8): 906-913.
25. Thompson JD, Higgins, DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994: 22 (22): 4673-4680.
26. Weir BS. Genetic data II. Sunderland, MA: Sinauer Associates, 1996.
27. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet 2003: 73 (1): 115-130.
28. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002: 30 (1): 97-101.
29. Di Bitondo R, Hall AJ, Peake IR, Iacoviello L, Winship PR. Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region. Hum Mol Genet 2002: 11 (7): 723-731.
30. Carew JA, Jackson AA, Bauer KA. ARP1 interacts with the 5′ flanking region of the coagulation factor VII gene. J Thromb Haemost 2003: 1 (6): 1220-1227.
31. Kudaravalli R, Tidd T, Pinotti M et al. Polymorphic changes in the 5′ flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost 2002: 88 (5): 763-767.
32. Greenberg D, Miao CH, Ho WT, Chung DW, Davie EW. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 1995: 92 (26): 12347-12351.
33. Erdmann D, Heim J. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 1995: 270 (39): 22988-22996.
34. Shamsher MK, Chuzhanova NA, Friedman B et al. Identification of an intronic regulatory element in the human protein C (PROC) gene. Hum Genet 2000: 107 (5): 458-465.
35. Bernardi F, Marchetti G, Pinotti M et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996: 16 (1): 72-76.
36. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. Arterioscler Thromb Vasc Biol 1997: 17 (11): 2825-2829.
37. Girelli D, Russo C, Ferraresi P et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000: 343 (11): 774-780.
38. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996: 75 (4): 567-572.
39. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003: 33 (Suppl.): 228-237.
40. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996: 273 (5281): 1516-1517.
41. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. Nat Genet 1997: 17 (1): 21-24.